Phase 2
Completed N=143
A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)
Source: ClinicalTrials.gov NCT00792935 ↗Enrolled (actual)
143
Serious AEs
1.4%
Results posted
Oct 2012
Primary outcomePrimary: Change From Baseline to Week 6 in 24-hour Weighted Mean Glucose — -43.4; -44.2 mg/dL — p=0.847
Summary
The purpose of this study is to test the effect of MK-0941 as add-on therapy for participants taking metformin for type 2 diabetes.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline to Week 6 in 24-hour Weighted Mean Glucose |
-43.4; -44.2 | 0.847 |
| PRIMARY Number of Participants Who Experienced One or More Episodes of Hypoglycemia (Symptomatic or Asymptomatic) |
32; 37 | 0.361 |
Eligibility Criteria
Inclusion Criteria
- Patient has type 2 diabetes mellitus
- Between the ages of 18 and 70
Exclusion Criteria
- Patient has a history of type 1 diabetes mellitus or ketoacidosis.
- Patient is on a weight loss program and is not in the maintenance phase or is taking weight loss medication.
- Patient has had surgery within 30 days of starting the study or has planned major surgery during the study
Data sourced from ClinicalTrials.gov (NCT00792935). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.